Neurotrophic factors and Alzheimer’s disease: are we focusing on the wrong molecule?
Brain derived neurotrophic factor (BDNF) promotes cholinergic neuron function and survival. In Alzheimer’s disease, BDNF mRNA and protein are decreased in basal forebrain cholinergic neuron target tissues such as cortex and hippocampus. Using RT-PCR, we demonstrate that BDNF is synthesized in basal forebrain, supplying cholinergic neurons with a local as well as a target-derived source of this factor. BDNF mRNA levels are decreased 50% in nucleus basalis of Alzheimer disease patients compared to controls. Thus, not only do the basal forebrain cholinergic neurons have a reduced supply of target-derived BDNF, but also of local BDNF. We also show by Western blotting that human CNS tissue contains both proBDNF and mature BDNF protein. Moreover, we demonstrate a significant (2.25-fold) deficit in proBDNF protein in Alzheimer’s disease parietal cortex compared to controls. Thus, reduced BDNF mRNA and protein levels in Alzheimer’s disease suggests that BDNF administration may be an effective therapeutic strategy for this disorder.
KeywordsNerve Growth Factor Brain Derive Neurotrophic Factor Basal Forebrain Nucleus Basalis Basal Forebrain Cholinergic Neuron
Unable to display preview. Download preview PDF.
- Appel SH.(1981) A unifying hypothesis for the cause of amyotrophic lateral sclerosis,parkinsonism,and Alzheimer disease.Ann Neurol10:499–505Google Scholar
- Castren E, Thoenen H, Lindholm D (1995) Brain-derived neurotrophic factor mRNA isexpressed in the septum,hypothalamus and in adrenergic brain stem nuclei of adult250M. Fahnestock et al.rat brain and is increased by osmotic stimulation in the paraventricular nucleus. Neuroscience 64: 71–80CrossRefGoogle Scholar
- Chen KS, Nishimura MC, Armanini MP, Crowley C, Spencer SD, Phillips HS (1997) Disruption of a single allele of the nervegrowth factor gene results in atrophy of basal forebrain cholinergic neurons and memory deficits. J Neurosci 17: 288–7296Google Scholar
- Eriksdotter JonhagenM, Nordberg A, Amberla K, Backman L, Ebendal T, Meyerson B, Olson L, Seiger A, Shigeta M, Theodorsson E, Viitanen M, Winblad B, Wahlund L-O (1998) Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer’s disease. Dement Geriatr Cogn Disord 9: 246–257CrossRefGoogle Scholar
- Knusel B, Beck KD, Winslow JW, Rosenthal A, Burton LE, Widmier HR, Nikolics K, Hefti F (1992) Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain. J Neurosci 12: 4391–4402PubMedGoogle Scholar
- Koliatsos VE, Applegate MD, Knusel B, Junard EO, Burton LE, Mobley WC, Hefti FF, Price DL (1991) Recombinant human nerve growth factor prevents retrograde degeneration of axotomized basal forebrain cholinergic neurons in the rat. Expurol 112:161–173Google Scholar
- Morse JK, Wiegand SJ, Anderson K, You YM, Cai N, Carnahan J, Miller J, Distefano PS, Altar CA, Lindsay RM, Alderson RF (1993) Brain-derived neurotrophic factor (BDNF) prevents the degeneration of medial septal cholinergic neurons following fimbria transection. J Neurosci 13: 4146–4156PubMedGoogle Scholar
- M. Fahnestock et al: Reduced brain-derived neurotrophic factor in ADGoogle Scholar
- Rice FL, Albers KM, Davis BM, Silos-Santiago I, Wilkinson GA, LeMaster AM, ErnforsP, Smeyne RJ, Aldskogius H, Phillips HS, Barbacid M, DeChiara TM, YancopoulosGD, Dunne CE, Fundin BT (1998) Differential dependency of unmyelinated and Adelta epidermal and upper dermal innervation on neurotrophins, trk receptors, andp75LNGFR. Dev Biol 198: 57–81Google Scholar
- Schober A, Wolf N, Huber K, Hertel R, Krieglstein K, Minichiello L, Kahane N,Widenfalk J, Kalcheim C, Olson L, Klein R, Lewin GR, Unsicker K, (1998) TrkB andneurotrophin-4 are important for development and maintenance of sympatheticpreganglionic neurons innervating the adrenal medulla. J Neurosci 18: 7272–7284PubMedGoogle Scholar
- Williams LR, Inouye G, Cummins V, Pelleymounter MA (1996) Glial cell line derivedneurotrophic factor sustains axotomized basal forebrain cholinergic neurons in vivo:dose-response comparison to nerve growth factor and brain-derived neurotrophicfactor. J Pharmacol Exp Ther 277: 1140–1151PubMedGoogle Scholar